Avenue Biosciences raised a $5.7M seed extension co-led by Balnord and Tesi, joined by Voima Ventures, Inventure, University of Helsinki, and Dimerent.
02 January 2026
02 January 2026
Total investments received (USD): 8.2M
Round value (USD): 5.7M
Company: Avenue Biosciences
Related deals
Brainomix in a £4.8 million Series C extension co-led by Parkwalk and Hostplus, joined by Modi Ventures.
Investments
13 February 2026
BaCta raised €7 million seed with LocalGlobe, Daphni, OVNI Capital, and business angels in France
Investments
09 February 2026
Centauri Therapeutics secured a £6 million series A extension investment from the AMR Action Fund,
Investments
08 February 2026
Tozaro in a £6M financing round with equity contributed by Mercia Ventures and Midlands Engine Investment Fund in the UK
Investments
06 February 2026
Zenniz in a $6 million seed round with Butterfly Ventures, Superhero Capital, Seventure Partners
Investments
06 February 2026
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Sweden
Ireland
Italy
Portugal
Spain